Evidence map›Paper›PMID 35191544›Full record

ArticleThe Journal of dermatology2022

Exacerbation of systemic lupus erythematosus after receiving mRNA-1273-based coronavirus disease 2019 vaccine.

Tomohiro Sugimoto, Ai Yorishima, Naoya Oka, Sho Masuda, Yusuke Yoshida, Shintaro Hirata

Abstract readLetter
In one paragraph

Article in The Journal of dermatology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Cubital Tunnel Syndrome Temporally after COVID-19 Vaccination.Tropical medicine and infectious disease · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Tomohiro SugimotoDepartment of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Hiroshima, Japan.ORCID 0000-0002-0968-9081
Ai YorishimaDepartment of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Hiroshima, Japan.
Naoya OkaDepartment of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Hiroshima, Japan.
Sho MasudaDepartment of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Hiroshima, Japan.
Yusuke YoshidaDepartment of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Hiroshima, Japan.ORCID 0000-0002-0774-0509
Shintaro HirataDepartment of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Hiroshima, Japan.ORCID 0000-0002-2474-9943

Funding

Kaken Pharmaceutical 19K07940
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Lupus Erythematosus, Systemic2019-nCoV Vaccine mRNA-1273COVID-19 VaccinesHumans2019-nCoV Vaccine mRNA-1273COVID-19 Vaccines

Identifiers

PMID35191544
PMCPMC9111274

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.